ENCINO, Calif., May 15, 2018 /PRNewswire/ -- Research
Solutions, Inc. (OTCQB: RSSS), a provider of workflow efficiency solutions for R&D-driven organizations, reported financial
results for its fiscal third quarter ended March 31, 2018.
Fiscal Third Quarter 2018 Highlights vs. Year-Ago Quarter
- Total revenue increased 10% to $7.3 million.
- Platform revenue up 81% to $489,000, with a 79% increase in total Platform deployments to
208. Annual recurring revenue was up 76% to $2.0 million.
- Transaction revenue up 7% to $6.8 million, with customer count up 8% to 1,059. Transaction
count up 3% to 219,607.
- Total gross margin up 240 basis points to 26.3%.
- Net loss from continuing operations was $0.3 million, or $(0.01) per share, compared to a net loss of $0.8 million, or $(0.03) per share.
Management Commentary
"Our third quarter demonstrates the continued momentum in our strategy to deliver unique workflow efficiency solutions to
research-driven organizations in life sciences, technology and academia," said Peter Derycz,
president and CEO of Research Solutions. "This can be seen in our fourth consecutive quarter of approximately 10% total revenue
growth and annual recurring revenue in our SaaS Platforms business that has surpassed $2
million.
"We expect our momentum to continue in the remainder of 2018 as we launch version 2.1 and 2.2 of our Platform framework,
supported by powerful weekly releases or improvements to smart applications we develop called 'gadgets.' This will be supported
by a sales and marketing team that we are reconstructing to drive optimum efficiency and investment returns."
Fiscal Third Quarter 2018 Financial Results
Total revenue increased 10% to $7.3 million compared to $6.6
million in the same year-ago quarter.
Platform subscription revenue increased 81% to $489,000 compared to $271,000 in the year-ago quarter. The increase was due to a 79% increase in the total number of paid Platform
deployments to 208. The quarter ended with annual recurring revenue up 76% to $2.0 million (see the
company's definition of annual recurring revenue below).
Transaction revenue increased 7% to $6.8 million compared to $6.4
million in the same year-ago quarter. Total active customers increased 8% from 985 to 1,059, and transaction count
increased 3% from 213,000 to 220,000 (see the company's definition of active customer accounts and transactions below).
Total gross margin increased 240 basis points to 26.3% from 23.9% in the same year-ago quarter. The increase was driven by a
100 basis point increase in Transactions gross margin and a revenue mix shift to the higher-margin Platforms business.
Total operating expenses decreased to $2.2 million compared to $2.4
million in the same year-ago quarter. The decrease was primarily due to the continued optimization of sales and marketing
resources and open positions.
Net loss from continuing operations improved to $0.3 million, or $(0.01) per share, compared to a net loss of $0.8 million, or $(0.03) per share, in the year-ago quarter. Adjusted EBITDA totaled $(0.1)
million compared to $(0.6) million in the year-ago quarter (see definition and further
discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).
Cash and cash equivalents at March 31, 2018 were $4.8 million
compared to $5.8 million at June 30, 2017. There were no outstanding
borrowings under the company's $2.5 million revolving line of credit. Apart from a $0.2 million office lease liability due to new accounting guidance for leases, the company had no long-term
liabilities or other debt.
Further details about these results are available in the company's quarterly report on Form 10-Q, which is available in the
investor relations section of the company's website at www.researchsolutions.com.
Conference Call
Research Solutions President and CEO Peter Derycz and CFO Alan
Urban will host an investor conference call to discuss these results and the company's outlook, followed by a question and
answer period.
Date: Tuesday, May 15, 2018
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: 1-855-327-6837
International dial-in number: 1-631-891-4304
Conference ID: 10004686
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and
organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.
The conference call will be broadcast live and available for replay here and via the investor
relations section of the company's website at www.researchsolutions.com.
A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day
through May 29, 2018.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 10004686
Fiscal Third Quarter 2018 Financial and Operational Summary Tables vs. Year-Ago Quarter
|
|
Quarter Ended March 31,
|
|
Nine Months Ended March 31,
|
|
|
2018
|
2017
|
Change
|
%
|
|
2018
|
2017
|
Change
|
%
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
Platforms
|
$ 489,219
|
$ 270,920
|
$ 218,299
|
80.6%
|
|
$ 1,290,568
|
$ 662,129
|
$ 628,439
|
94.9%
|
|
Transactions
|
6,792,289
|
6,372,679
|
419,610
|
6.6%
|
|
19,562,000
|
18,245,640
|
1,316,360
|
7.2%
|
|
Total Revenue
|
7,281,508
|
6,643,599
|
637,909
|
9.6%
|
|
20,852,568
|
18,907,769
|
1,944,799
|
10.3%
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit:
|
|
|
|
|
|
|
|
|
|
|
Platforms
|
386,034
|
212,553
|
173,481
|
81.6%
|
|
1,013,034
|
528,175
|
484,859
|
91.8%
|
|
Transactions
|
1,532,330
|
1,374,837
|
157,493
|
11.5%
|
|
4,390,639
|
3,868,109
|
522,530
|
13.5%
|
|
Total Gross Profit
|
1,918,364
|
1,587,390
|
330,974
|
20.9%
|
|
5,403,673
|
4,396,284
|
1,007,389
|
22.9%
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit as a % of revenue:
|
|
|
|
|
|
|
|
|
|
|
Platforms
|
78.9%
|
78.5%
|
0.5%
|
|
|
78.5%
|
79.8%
|
-1.3%
|
|
|
Transactions
|
22.6%
|
21.6%
|
1.0%
|
|
|
22.4%
|
21.2%
|
1.2%
|
|
|
Total Gross Profit
|
26.3%
|
23.9%
|
2.5%
|
|
|
25.9%
|
23.3%
|
2.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
522,894
|
698,346
|
(175,452)
|
-25.1%
|
|
1,726,443
|
1,683,704
|
42,739
|
2.5%
|
|
Technology and product development
|
436,672
|
396,765
|
39,907
|
10.1%
|
|
1,343,995
|
1,062,790
|
281,204
|
26.5%
|
|
General and administrative
|
1,091,930
|
1,120,481
|
(28,551)
|
-2.5%
|
|
3,322,127
|
3,341,788
|
(19,660)
|
-0.6%
|
|
Depreciation and amortization
|
32,768
|
33,906
|
(1,138)
|
-3.4%
|
|
119,666
|
96,801
|
22,865
|
23.6%
|
|
Stock-based compensation
|
114,340
|
112,326
|
2,014
|
1.8%
|
|
715,147
|
518,012
|
197,135
|
38.1%
|
|
Foreign currency translation loss
|
(9,737)
|
6,272
|
(16,009)
|
-255.2%
|
|
(22,609)
|
27,227
|
(49,836)
|
-183.0%
|
|
Total Operating Expenses
|
2,188,866
|
2,368,095
|
(179,229)
|
-7.6%
|
|
7,204,769
|
6,730,322
|
474,447
|
7.0%
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
(270,502)
|
(780,705)
|
510,203
|
65.4%
|
|
(1,801,096)
|
(2,334,038)
|
532,942
|
22.8%
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expenses):
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
2,000
|
(3,000)
|
5,000
|
166.7%
|
|
(4,000)
|
(9,000)
|
5,000
|
55.6%
|
|
Other income (expense)
|
13,769
|
10,143
|
3,626
|
35.7%
|
|
37,883
|
20,277
|
17,606
|
86.8%
|
|
Provision for income taxes
|
(10,531)
|
(5,544)
|
(4,987)
|
-90.0%
|
|
(32,098)
|
(28,486)
|
(3,612)
|
-12.7%
|
|
Income from discontinued operations
|
-
|
141,616
|
(141,616)
|
-100.0%
|
|
-
|
460,131
|
(460,131)
|
-100.0%
|
|
Gain on sale of discontinued operations
|
69,277
|
-
|
69,277
|
|
|
205,779
|
-
|
205,779
|
|
|
Total Other Income (Expenses):
|
74,515
|
143,215
|
(68,700)
|
-48.0%
|
|
207,564
|
442,922
|
(235,358)
|
-53.1%
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
$ (195,987)
|
$ (637,490)
|
$ 441,503
|
69.3%
|
|
$ (1,593,532)
|
$ (1,891,116)
|
$ 297,584
|
15.7%
|
|
|
|
|
|
|
|
|
|
|
|
Platforms:
|
|
|
|
|
|
|
|
|
|
|
ARR (Annual recurring revenue)
|
|
|
|
|
|
$ 1,982,867
|
$ 1,124,451
|
$ 858,416
|
76.3%
|
|
Deployments
|
|
|
|
|
|
208
|
116
|
92
|
79.3%
|
|
ASP (Average sales price)
|
|
|
|
|
|
$ 9,533
|
$ 9,694
|
$ (161)
|
-1.7%
|
|
Transactions:
|
|
|
|
|
|
|
|
|
|
|
Transaction count
|
219,607
|
212,827
|
6,780
|
3.2%
|
|
629,692
|
597,697
|
31,995
|
5.4%
|
|
Corporate customers
|
848
|
802
|
46
|
5.7%
|
|
823
|
773
|
50
|
6.5%
|
|
Academic customers
|
211
|
183
|
28
|
15.3%
|
|
218
|
179
|
39
|
21.7%
|
|
Total customers
|
1,059
|
985
|
74
|
7.5%
|
|
1,042
|
952
|
89
|
9.4%
|
Active Customer Accounts, Transactions and Annual Recurring Revenue
The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the
period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with
at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The company defines annual recurring revenue as the value of contracted Platform subscription recurring revenue normalized to
a one-year period.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the
company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP
measure provides useful information about the company's operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial
measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency
transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, income from discontinued
operations, gain on sale of discontinued operations, and other potential adjustments that may arise.
Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
|
Quarter Ended March 31,
|
|
Nine Months Ended March 31,
|
|
|
|
2018
|
2017
|
Change
|
|
2018
|
2017
|
Change
|
|
Net Income (loss)
|
$ (195,987)
|
$ (637,490)
|
$ 441,503
|
|
$ (1,593,532)
|
$ (1,891,116)
|
$ 297,584
|
|
Add (deduct):
|
|
|
|
|
|
|
|
|
|
Interest expense
|
(2,000)
|
3,000
|
(5,000)
|
|
4,000
|
9,000
|
(5,000)
|
|
|
Other income (expense)
|
(13,769)
|
(10,143)
|
(3,626)
|
|
(37,883)
|
(20,277)
|
(17,606)
|
|
|
Foreign currency translation loss
|
(9,737)
|
6,272
|
(16,009)
|
|
(22,609)
|
27,227
|
(49,836)
|
|
|
Provision for income taxes
|
10,531
|
5,544
|
4,987
|
|
32,098
|
28,486
|
3,612
|
|
|
Depreciation and amortization
|
32,768
|
33,906
|
(1,138)
|
|
119,666
|
96,801
|
22,865
|
|
|
Stock-based compensation
|
114,340
|
112,326
|
2,014
|
|
715,147
|
518,012
|
197,135
|
|
|
Income from discontinued operations
|
-
|
(141,616)
|
141,616
|
|
-
|
(460,131)
|
460,131
|
|
|
Gain on sale of discontinued operations
|
(69,277)
|
-
|
(69,277)
|
|
(205,779)
|
-
|
(205,779)
|
|
Adjusted EBITDA
|
$ (133,131)
|
$ (628,201)
|
$ 495,070
|
|
$ (988,892)
|
$ (1,691,998)
|
$ 703,106
|
About Research Solutions
Research Solutions, Inc. (OTCQB: RSSS) provides workflow efficiency solutions for R&D-driven organizations in life
sciences, technology and academia worldwide. Our Software-as-a-Service platform provides tools or "Gadgets" that allow users to
discover, access, manage and collaborate around science, technology and medical (STM) content and data. Our customers range from
70+% of the top 25 global pharmaceutical companies to emerging small and medium-sized businesses. We generate recurring revenue
from subscriptions to our SaaS platform and transactional revenue from the sale of STM content. For more information, visit
www.researchsolutions.com.
Important Cautions Regarding Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements. Such matters involve risks and
uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions;
general competitive factors; acceptance of the company's products in the market; the company's success in obtaining new customers
and new Platform deployments; the company's success in technology and product development; the company's ability to execute its
business model and strategic plans; the company's success in integrating acquired entities and assets, and all the risks and
related information described from time to time in the company's filings with the Securities and Exchange Commission ("SEC"),
including the financial statements and related information contained in the company's Securities and Exchange Commission Annual
Report on Form 10-K and interim Quarterly Reports on Form 10-Q. The company assumes no obligation to update the cautionary
information in this release.
|
Research Solutions, Inc. and Subsidiaries
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
March 31 ,
|
|
June 30,
|
|
|
2018
|
|
2017
|
|
|
(unaudited)
|
|
|
|
Assets
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
4,801,305
|
|
$
|
5,773,950
|
|
Accounts receivable, net of allowance of $119,462 and $119,536,
respectively
|
|
|
4,336,057
|
|
|
5,465,299
|
|
Prepaid expenses and other current assets
|
|
|
302,811
|
|
|
196,820
|
|
Prepaid royalties
|
|
|
127,906
|
|
|
566,282
|
|
Total current assets
|
|
|
9,568,079
|
|
|
12,002,351
|
|
|
|
|
|
|
|
|
Other assets:
|
|
|
|
|
|
|
|
Property and equipment, net of accumulated depreciation of $741,398
and $699,421, respectively
|
|
|
72,434
|
|
|
85,737
|
|
Intangible assets, net of accumulated amortization of $701,436 and
$623,714, respectively
|
|
|
21,600
|
|
|
41,870
|
|
Deposits and other assets
|
|
|
14,459
|
|
|
14,466
|
|
Right of use asset, net of accumulated amortization of $99,864 and $45,105,
respectively
|
|
|
335,380
|
|
|
417,917
|
|
Total assets
|
|
$
|
10,011,952
|
|
$
|
12,562,341
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$
|
4,687,974
|
|
$
|
6,443,056
|
|
Deferred revenue
|
|
|
1,652,160
|
|
|
1,335,475
|
|
Lease liability, current portion
|
|
|
117,507
|
|
|
110,888
|
|
Total current liabilities
|
|
|
6,457,641
|
|
|
7,889,419
|
|
|
|
|
|
|
|
|
Long-term liabilities:
|
|
|
|
|
|
|
|
Lease liability, long-term portion
|
|
|
239,555
|
|
|
328,299
|
|
Total liabilities
|
|
|
6,697,196
|
|
|
8,217,718
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity :
|
|
|
|
|
|
|
|
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares
issued and outstanding
|
|
|
-
|
|
|
-
|
|
Common stock; $0.001 par value; 100,000,000 shares authorized; 23,980,383
and 23,883,145 shares issued and outstanding, respectively
|
|
|
23,980
|
|
|
23,883
|
|
Additional paid-in capital
|
|
|
22,853,945
|
|
|
22,267,327
|
|
Accumulated deficit
|
|
|
(19,469,389)
|
|
|
(17,875,858)
|
|
Accumulated other comprehensive loss
|
|
|
(93,780)
|
|
|
(70,729)
|
|
Total stockholders' equity
|
|
|
3,314,756
|
|
|
4,344,623
|
|
Total liabilities and stockholders' equity
|
|
$
|
10,011,952
|
|
$
|
12,562,341
|
|
Research Solutions, Inc. and Subsidiaries
|
|
Condensed Consolidated Statements of Operations and Other Comprehensive
Loss
|
|
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
March 31 ,
|
|
March 31 ,
|
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Platforms
|
|
$
|
489,219
|
|
$
|
270,920
|
|
$
|
1,290,568
|
|
$
|
662,129
|
|
Transactions
|
|
|
6,792,289
|
|
|
6,372,679
|
|
|
19,562,000
|
|
|
18,245,640
|
|
Total revenue
|
|
|
7,281,508
|
|
|
6,643,599
|
|
|
20,852,568
|
|
|
18,907,769
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Platforms
|
|
|
103,185
|
|
|
58,367
|
|
|
277,534
|
|
|
133,954
|
|
Transactions
|
|
|
5,259,959
|
|
|
4,997,842
|
|
|
15,171,361
|
|
|
14,377,531
|
|
Total cost of revenue
|
|
|
5,363,144
|
|
|
5,056,209
|
|
|
15,448,895
|
|
|
14,511,485
|
|
Gross profit
|
|
|
1,918,364
|
|
|
1,587,390
|
|
|
5,403,673
|
|
|
4,396,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
2,156,097
|
|
|
2,334,189
|
|
|
7,085,102
|
|
|
6,633,521
|
|
Depreciation and amortization
|
|
|
32,768
|
|
|
33,906
|
|
|
119,666
|
|
|
96,801
|
|
Total operating expenses
|
|
|
2,188,865
|
|
|
2,368,095
|
|
|
7,204,768
|
|
|
6,730,322
|
|
Loss from operations
|
|
|
(270,501)
|
|
|
(780,705)
|
|
|
(1,801,095)
|
|
|
(2,334,038)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expenses):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
2,000
|
|
|
(3,000)
|
|
|
(4,000)
|
|
|
(9,000)
|
|
Other income
|
|
|
13,769
|
|
|
10,143
|
|
|
37,883
|
|
|
20,277
|
|
Total other income
|
|
|
15,769
|
|
|
7,143
|
|
|
33,883
|
|
|
11,277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations before provision for income taxes
|
|
|
(254,732)
|
|
|
(773,562)
|
|
|
(1,767,212)
|
|
|
(2,322,761)
|
|
Provision for income taxes
|
|
|
(10,531)
|
|
|
(5,544)
|
|
|
(32,098)
|
|
|
(28,486)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations
|
|
|
(265,263)
|
|
|
(779,106)
|
|
|
(1,799,310)
|
|
|
(2,351,247)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations
|
|
|
-
|
|
|
141,616
|
|
|
-
|
|
|
460,131
|
|
Gain from sale of discontinued operations
|
|
|
69,277
|
|
|
-
|
|
|
205,779
|
|
|
-
|
|
Income from discontinued operations
|
|
|
69,277
|
|
|
141,616
|
|
|
205,779
|
|
|
460,131
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(195,986)
|
|
|
(637,490)
|
|
|
(1,593,531)
|
|
|
(1,891,116)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss):
Foreign currency translation
|
|
|
(7,385)
|
|
|
(18,090)
|
|
|
(23,051)
|
|
|
(16,178)
|
|
Comprehensive loss
|
|
$
|
(203,371)
|
|
$
|
(655,580)
|
|
$
|
(1,616,582)
|
|
$
|
(1,907,294)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share from continuing operations, basic and diluted
|
|
$
|
(0.01)
|
|
$
|
(0.03)
|
|
$
|
(0.08)
|
|
$
|
(0.10)
|
|
Income per share from discontinued operations, basic and diluted
|
|
$
|
-
|
|
$
|
-
|
|
$
|
0.01
|
|
$
|
0.02
|
|
Net loss per share, basic and diluted
|
|
$
|
(0.01)
|
|
$
|
(0.03)
|
|
$
|
(0.07)
|
|
$
|
(0.08)
|
|
Weighted average common shares outstanding, basic and diluted
|
|
|
23,498,796
|
|
|
23,265,939
|
|
|
23,444,569
|
|
|
23,199,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View original content with multimedia:http://www.prnewswire.com/news-releases/research-solutions-reports-fiscal-third-quarter-2018-financial-results-300648941.html
SOURCE Research Solutions, Inc.